Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
Infectious diseases (IDs) still take 14 million lives worldwide each year, making up a quarter of total deaths. This makes them a leading cause of mortality. The management of IDs is dependent on ...
In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.
BGI Genomics' multiplex bacterial resistance genes detection kit, multiplex nucleic acid kit for respiratory pathogens and central nervous system (CNS) pathogen identification test kit based on PM ...
IRVINE, Calif., April 26, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical ...
Viral diseases pose a significant global health challenge, placing substantial strain on healthcare systems. Accurate identification of viral infections is crucial for monitoring outbreaks, managing ...
Zacks Investment Research on MSN
CODX shares dip despite Australian patent grant for Co-Dx PCR platform
CoDiagnostics CODX recently announced that the Australian Patent Office has granted a patent covering its new Co-Dx PCR platform, marking the first patent issued for this point-of-care technology.
The Australian patent represents the first patent granted for the Company's new point-of-care testing platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback